{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:21:30Z","timestamp":1793042490043,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier","isbn-type":[{"value":"9780128127766","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.pmbts.2017.03.003","type":"book-chapter","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T22:16:26Z","timestamp":1493936186000},"page":"305-325","source":"Crossref","is-referenced-by-count":128,"title":["Matrix Metalloproteinases and Synovial Joint Pathology"],"prefix":"10.1016","author":[{"given":"Charles J.","family":"Malemud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2017.03.003_bb0005","series-title":"Role of Proteases in Cellular Dysfunction","first-page":"63","article-title":"Regulation of chondrocyte matrix metalloproteinase gene expression","author":"Malemud","year":"2013"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biocel.2008.01.024","article-title":"The role of proteases in pathologies of the synovial joint","volume":"40","author":"Jones","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteases","volume":"274","author":"Nagase","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2741\/1818","article-title":"MMPs and ADAMTS: functional studies","volume":"11","author":"Flannery","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPS","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0049-0172(92)90048-I","article-title":"Collagenase in synovitis of rheumatoid arthritis","volume":"22","author":"Sorsa","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2741\/A388","article-title":"Degradative enzymes in osteoarthritis","volume":"11","author":"Smith","year":"1999","journal-title":"Front Biosci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2741\/1916","article-title":"Matrix metalloproteinases: role in skeletal development and growth plate disorders","volume":"11","author":"Malemud","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0050","first-page":"355","article-title":"Matrix metalloproteinases in the formation of human synovial joint cavities","volume":"188","author":"Edwards","year":"1996","journal-title":"J Anat"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitor of metalloproteinases: structure, function and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0060","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1016\/S0021-9258(19)38559-X","article-title":"Structure of the human type IV collagenase gene","volume":"19","author":"Huhtala","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.23951","article-title":"The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice","volume":"124","author":"Ezhilarasan","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11739-009-0283-y","article-title":"Matrix metalloproteinases and peripheral arterial disease","volume":"5","author":"Busti","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1042\/BST0350689","article-title":"Matrix metalloproteinases: useful and deleterious","volume":"35","author":"Ganea","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2014.09.016","article-title":"Myocardial matrix metalloproteinase-2: inside out and upside down","volume":"77","author":"DeCoux","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.expneurol.2016.07.018","article-title":"Deficiency in matrix metalloproteinase-2 results in long-term vascular instability and regression in the injured mouse spinal cord","volume":"284","author":"Trivedi","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/bbrc.1999.0153","article-title":"Regulation of proMMP-1 and proMMP-3 activation by tissue factor pathway inhibitor-2\/matrix-associated serine protease inhibitor","volume":"255","author":"Rao","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0095","doi-asserted-by":"crossref","first-page":"13055","DOI":"10.1074\/jbc.271.22.13055","article-title":"Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression","volume":"27","author":"Ye","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0100","doi-asserted-by":"crossref","first-page":"16918","DOI":"10.1016\/S0021-9258(18)37479-9","article-title":"Purification and properties of a small latent matrix metalloproteinase of the rat uterus","volume":"263","author":"Woessner","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/cmdc.201000550","article-title":"The discovery of MMP7 inhibitors exploiting a novel selectivity trigger","volume":"6","author":"Edman","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0110","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1021\/bi00499a008","article-title":"Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase","volume":"29","author":"Mallya","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1164\/ajrccm.159.6.9809043","article-title":"Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema","volume":"159","author":"Betsuyaku","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/bj3040347","article-title":"Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan","volume":"304","author":"Fosang","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0125","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-07-5154","article-title":"Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion","volume":"68","author":"Guti\u00e9rrez-Fern\u00e1ndez","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0130","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1074\/jbc.274.19.13066","article-title":"Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin\/stromelysin-1 cascade enhances tumor cell invasion","volume":"274","author":"Ramos-DeSimone","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s000180050495","article-title":"Matrix metalloproteinases in tumor invasion","volume":"57","author":"Johansson","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1242\/jcs.109.5.953","article-title":"MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis","volume":"109","author":"Kinoh","year":"1996","journal-title":"J Cell Sci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1699-0463.1999.tb01524.x","article-title":"Mechanisms of pro matrix metalloproteinase activation","volume":"107","author":"Murphy","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0038-1657576","article-title":"Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion","volume":"78","author":"Sato","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0155","doi-asserted-by":"crossref","first-page":"20970","DOI":"10.1074\/jbc.M111.237669","article-title":"Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects","volume":"286","author":"Golubkov","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15216540600962818","article-title":"MT1-MMP: a key regulator of cell migration in tissue","volume":"58","author":"Itoh","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0165","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.rhu.0000166673.34461.33","article-title":"Immunologic mechanisms in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Firestein","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4065\/81.1.94","article-title":"Genetics of rheumatoid arthritis","volume":"81","author":"Turesson","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2006.04.011","article-title":"Molecular and cellular basis of rheumatoid arthritis destruction","volume":"106","author":"Karouzakis","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0180","first-page":"002","article-title":"Diagnostic, prognostic and therapeutic biomarkers for rheumatoid arthritis","volume":"S6","author":"McGeough","year":"2012","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","article-title":"Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis","volume":"1050","author":"Greiner","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0190","first-page":"516","article-title":"Anti-citrullinated peptide antibodies is more than an accurate tool for diagnosis of rheumatoid arthritis","volume":"15","author":"Goldman","year":"2013","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0195","first-page":"001","article-title":"Immunotherapy of tocilizumab for rheumatoid arthritis","volume":"S6","author":"Tanaka","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0200","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.090074","article-title":"Anakinra for rheumatoid arthritis: a systematic review","volume":"36","author":"Mertens","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157436209789057467","article-title":"Targeting JAK\/STAT signaling pathway in inflammatory diseases","volume":"4","author":"Malemud","year":"2009","journal-title":"Curr Signal Transduct Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4172\/2155-9899.1000160","article-title":"Intracellular signaling pathways in rheumatoid arthritis","volume":"4","author":"Malemud","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0215","series-title":"Drug Discovery","first-page":"373","article-title":"Suppression of pro-inflammatory cytokines via targeting of STAT-responsive genes","author":"Malemud","year":"2013"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0220","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4172\/2155-9899.1000422","article-title":"Matrix metalloproteinase-9 production in immortalized human chondrocyte lines","volume":"7","author":"Malemud","year":"2016","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4172\/2161-1149.1000113","article-title":"Monosodium urate and tumor necrosis factor-\u03b1 increase apoptosis in human chondrocyte cultures","volume":"2","author":"Malemud","year":"2012","journal-title":"Rheumatology (Sunnyvale)"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0230","doi-asserted-by":"crossref","first-page":"304","DOI":"10.15761\/IMM.1000158","article-title":"Blockade of recombinant human IL-6 with tocilizumab suppresses matrix metalloproteinase-9 production in the C28\/I2 immortalized human chondrocyte cell line","volume":"2","author":"Meszaros","year":"2015","journal-title":"Integr Mol Med"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molimm.2012.08.018","article-title":"Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-\u03baB\/HIF-1\u03b1 pathway","volume":"53","author":"Li","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0240","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.jprot.2011.12.042","article-title":"Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF\/TOF","volume":"75","author":"Mateos","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3892\/mmr.2014.2182","article-title":"RNA-seq analysis of synovial fibroblasts in human rheumatoid arthritis","volume":"10","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0250","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1002\/art.30630","article-title":"Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement","volume":"63","author":"Noss","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0255","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2960","article-title":"Interferon-\u03b3 inhibit interleukin-1\u03b2-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis","volume":"12","author":"Page","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0260","first-page":"3048","article-title":"Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium","volume":"7","author":"Zhou","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0265","doi-asserted-by":"crossref","first-page":"214683","DOI":"10.1155\/2015\/214683","article-title":"Inhibitory effect of novel antirheumatic drug T-614 on the IL-6-induced RANKL\/OPG, IL-17, and MMP-3 expression in synovial fibroblasts from rheumatoid arthritis patients","volume":"2015","author":"Wei","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0270","doi-asserted-by":"crossref","first-page":"R224","DOI":"10.1186\/ar3211","article-title":"Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K\/BxN serum-transfer arthritis model","volume":"12","author":"Garcia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0275","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1002\/art.27757","article-title":"Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression","volume":"62","author":"Cox","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0280","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.4049\/jimmunol.0904068","article-title":"Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function","volume":"184","author":"Sabeh","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0285","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.24331","article-title":"Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis","volume":"60","author":"Miller","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0290","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/ar2358","article-title":"Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study","volume":"10","author":"Andreas","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0295","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ard.2008.106021","article-title":"Effect of oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis","volume":"69","author":"J\u00fcngel","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08916930600807709","article-title":"The expression of collagenase-3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis","volume":"39","author":"Wernicke","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/187152808784165199","article-title":"Molecular targets of rheumatoid arthritis","volume":"7","author":"Okamoto","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.imlet.2009.08.002","article-title":"Altered apoptosis of inflammatory neutrophils in MMP-9-deficient mice is due to lower expression and activity of caspase-3","volume":"126","author":"Kolaczkowska","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2040622312454157","article-title":"Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity","volume":"3","author":"Meszaros","year":"2012","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0320","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2013","article-title":"Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage","volume":"8","author":"Davidson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.joca.2005.09.004","article-title":"A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human cartilage aggrecanolysis","volume":"14","author":"Sandy","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.joca.2005.07.018","article-title":"Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments","volume":"14","author":"Struglics","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0000000000000162","article-title":"Biological basis of osteoarthritis: state of the evidence","volume":"27","author":"Malemud","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0340","first-page":"1","article-title":"The medical therapy of osteoarthritis: \u201cthinking outside the box\u201d","volume":"1","author":"Malemud","year":"2016","journal-title":"J Osteoarthritis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cyto.2007.06.001","article-title":"Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone","volume":"38","author":"Hulejov\u00e1","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0350","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/art.38401","article-title":"Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes","volume":"66","author":"Jackson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0355","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.joca.2014.09.007","article-title":"Intra-articular administration of xenogeneic neonatal mesenchymal stem cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis","volume":"23","author":"Saulnier","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.22337","article-title":"Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3","volume":"56","author":"Blom","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0365","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/1354750X.2015.1105497","article-title":"Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis","volume":"20","author":"Kjelgaard-Petersen","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ard.61.7.591","article-title":"Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model","volume":"61","author":"Salminen","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138920108783497659","article-title":"Joint diseases and matrix metalloproteinases: a role for MMP-13","volume":"9","author":"Takaishi","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0380","article-title":"Matrix metalloproteases and tissue inhibitors of metalloproteases in medial plica and pannus-like tissue contribute to knee osteoarthritis progression","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/17460816.3.3.253","article-title":"Is there a final common pathway for arthritis?","volume":"3","author":"Malemud","year":"2008","journal-title":"Futur Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0390","first-page":"205","article-title":"MMP-8 is only a minor gene product of human adult articular chondrocytes of the knee","volume":"21","author":"Stremme","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0395","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/art.34602","article-title":"Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints","volume":"64","author":"Weng","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-016-0031-5","article-title":"Secukinumab: a new treatment option for psoriatic arthritis","volume":"3","author":"Mease","year":"2016","journal-title":"Rheumatol Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0405","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.bor.0000167752.93543.76","article-title":"Pathogenesis of psoriatic arthritis","volume":"17","author":"Ritchlin","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0410","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0415","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar3781","article-title":"Functional role of IL-22 in psoriatic arthritis","volume":"14","author":"Mitra","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0420","first-page":"335","article-title":"MMP-2, MMP-9, TIMP-1, TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis","volume":"22","author":"Giannelli","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0425","first-page":"1274","article-title":"Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction","volume":"31","author":"Kane","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0430","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/1535370213506435","article-title":"Serological markers in psoriatic arthritis: promising tools","volume":"238","author":"Ramonda","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0435","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1740-2557-3-5","article-title":"Decreased levels of matrix metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-\u03b1","volume":"3","author":"Cordiali-Fei","year":"2006","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0440","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3899\/jrheum.121162","article-title":"Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis","volume":"40","author":"Chandran","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0445","first-page":"107","article-title":"Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis","volume":"29","author":"Hitchon","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0450","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/ijr.12.61","article-title":"The new ASAS classification criteria for axial and peripheral spondyloarthritis: promises and pitfalls","volume":"7","author":"Lipton","year":"2012","journal-title":"Int J Clin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0455","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","article-title":"Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthropathies","volume":"34","author":"Reveille","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0460","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.bor.0000231904.04548.09","article-title":"Matrix metalloproteinase expression in the spondyloarthropathies","volume":"18","author":"Zhu","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0465","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/978-1-4419-0298-6_9","article-title":"Biomarkers in spondyloarthropathies","volume":"649","author":"Chen","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0470","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.4238\/2015.December.16.7","article-title":"Serum matrix metalloproteinase-3 levels in patients with ankylosing spondylitis","volume":"14","author":"Gao","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0475","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","article-title":"Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis","volume":"56","author":"Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0480","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/ard.2008.092494","article-title":"Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis","volume":"68","author":"Neidhart","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0485","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3899\/jrheum.101128","article-title":"Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment of ankylosing spondylitis","volume":"38","author":"Arends","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0490","first-page":"659","article-title":"Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety","volume":"29","author":"Maksymowych","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0495","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2474-15-93","article-title":"The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0500","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar3857","article-title":"Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis","volume":"14","author":"Mattey","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0505","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1517\/14712598.2016.1167183","article-title":"Secukinumab (AIN457) in the treatment of ankylosing spondylitis","volume":"16","author":"Braun","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0510","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.4238\/2015.June.18.28","article-title":"Expression of TNF-\u03b1, VEGF, and MMP-3 mRNAs in synovial tissues and their role in fibroblast-mediated osteogenesis in ankylosing spondylitis","volume":"14","author":"Liu","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.09.008","article-title":"An alternate perspective on the role of TIMPs and MMPs in pathology","volume":"180","author":"Moore","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0520","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0014-5793(01)02323-7","article-title":"Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)","volume":"494","author":"Hashimoto","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0525","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-4838(99)00279-4","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and function","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0530","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF03327357","article-title":"The pathophysiology of osteoarthritis","volume":"15","author":"Iannone","year":"2003","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0535","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/138945007779940098","article-title":"Molecular targets in osteoarthritis: metalloproteases and their inhibitors","volume":"8","author":"Burrage","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0540","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2004.12.013","article-title":"Cartilage breakdown in osteoarthritis","volume":"73","author":"Rannou","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0545","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gt.3301871","article-title":"Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3","volume":"10","author":"van der Laan","year":"2003","journal-title":"Gene Ther"},{"issue":"suppl 2","key":"10.1016\/bs.pmbts.2017.03.003_bb0550","doi-asserted-by":"crossref","first-page":"ii43","DOI":"10.1136\/ard.62.suppl_2.ii43","article-title":"Metalloproteinases, inflammation and rheumatoid arthritis","volume":"62","author":"Mohammed","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0555","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/rheumatology\/41.1.78","article-title":"Serum matrix metalloproteinases and tissue inhibitors of metalloproteases in different histological variants of rheumatoid synovitis","volume":"41","author":"Klimiuk","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0560","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2174\/138945009789753264","article-title":"Targeting matrix metalloproteinases in inflammatory conditions","volume":"10","author":"Clutterbuck","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0565","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/art.22879","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is expressed in osteoarthritis and forms a complex with matrix metalloproteinase-9","volume":"56","author":"Gupta","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"suppl B","key":"10.1016\/bs.pmbts.2017.03.003_bb0570","first-page":"S87","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is produced by IL-1\u03b2-stimulated human osteoarthritis chondrocytes and protects MMP-9 from degradation","volume":"14","author":"Gupta","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0575","series-title":"OA, Inflammation and Degradation: A Continuum","first-page":"99","article-title":"MAP kinases","volume":"vol 70","author":"Malemud","year":"2007"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0580","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coph.2006.11.012","article-title":"Inhibitors of stress-activated\/mitogen-activated protein kinase pathways","volume":"7","author":"Malemud","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0585","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis production of IL17A drives matrix degradation: synergy with tumour necrosis factor-\u03b1, Oncostatin M, and responses to biologic therapies","volume":"11","author":"Moran","year":"2009","journal-title":"Arthritis Ther Res"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0590","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signaling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0595","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/138955706777435670","article-title":"Small molecular weight inhibitors of stress-activated and mitogen-activated protein kinases","volume":"6","author":"Malemud","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0600","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/157436211795659883","article-title":"New organ-specific pharmacological strategies interfering with signaling pathways in inflammatory disorders\/autoimmune disorders","volume":"6","author":"Wisler","year":"2011","journal-title":"Curr Signal Transduct Ther"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0605","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10067-011-1833-z","article-title":"Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis","volume":"30","author":"Kanbe","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0610","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5312\/wjo.v5.i4.496","article-title":"Protein kinase small molecule inhibitors for rheumatoid arthritis: medicinal chemistry\/clinical perspectives","volume":"5","author":"Malemud","year":"2014","journal-title":"World J Orthop"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0615","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10753-011-9336-2","article-title":"The role of Raf kinase inhibitor protein in rheumatoid fibroblast-like synoviocytes invasiveness and cytokine and matrix metalloproteinase expression","volume":"35","author":"Ahn","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0620","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.joca.2009.11.005","article-title":"MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation\u2014divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation","volume":"18","author":"Sondergaard","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/bs.pmbts.2017.03.003_bb0625","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/13543776.2013.779254","article-title":"New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158)","volume":"23","author":"Li","year":"2011","journal-title":"Expert Opin Ther Pat"},{"issue":"suppl","key":"10.1016\/bs.pmbts.2017.03.003_bb0630","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0049-0172(81)90042-1","article-title":"Neutral proteinases from articular chondrocytes in culture that degrade synthetic substrates and cartilage macromolecules","volume":"11","author":"Malemud","year":"1981","journal-title":"Semin Arthritis Rheum"}],"container-title":["Progress in Molecular Biology and Translational Science","Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317300352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317300352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:32:13Z","timestamp":1750224733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117317300352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128127766"],"references-count":126,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2017.03.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}